
News|Videos|June 6, 2018
Exploring the Changing Landscape of ICI Tx in NSCLC
Author(s)Leena Gandhi, MD
In this video, Dr. Leena Gandhi discusses KEYNOTE-042, a study of pembrolizumab vs chemotherapy in NSCLC (abstract LBA4), and other key ICI trials reported at ASCO 2018.
Advertisement
In this video, Dr. Leena Gandhi discusses KEYNOTE-042, a study of pembrolizumab vs chemotherapy in NSCLC (abstract LBA4), and other key ICI trials reported at ASCO 2018.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
Epcoritamab Combo Shows Sustained Remissions in Follicular Lymphoma
2
Understanding The Training, Credentialing Landscapes for End-of-Life Doulas
3
Olomorasib Earns FDA Breakthrough Therapy in KRAS G12C+ Pancreatic Cancer
4
GLP-1 Receptor Agonists and Cancer: Renewed Momentum for Metabo-Oncology
5

























































